Main menu
  1. Home
  2.  » 
  3. About Us
  4.  » Corporate Responsibility
Corporate Responsibility

Fiscal 2020 Corporate Responsibility Report

Responsible business practices are essential to fulfilling our mission of helping people live better, healthier lives. Our corporate values are at the foundation of our culture and everything we do.

At Catalent, integrity, responsibility and sustainability are integrated into the heart of our business. We are proud of how our team of 15,000 talented employees is supporting our corporate responsibility commitment.

Our CR strategy stands on three pillars—People, Environment and Communities—and we have instituted a scorecard approach to monitor how each of the business units and sites across the Catalent network contributes to meeting our goals.

Our corporate responsibility and sustainability strategy is focused on the areas that we believe are the most material to our business, and is informed by our employees, communities, customers, investors and other key stakeholders.

That said, our CR strategy is more than a plan. It is who we are, and we continue to invest in a corporate culture that understands and prioritizes our impact on people; and aligns our operations and decision-making with our values—while creating long-term, sustainable value for all of our stakeholders.


As a leading contract development and manufacturing organization (CDMO), we work with life science customers to develop, launch and supply pharmaceutical, biologic, cell and gene therapy, and consumer health products. Our oral, injectable, cell and gene therapy, and respiratory delivery technologies address the full diversity of the pharmaceutical industry, including small molecules, protein, cell and gene therapy biologics, and consumer health products.


Putting patients first, investing in and showing respect for our people, and promoting a responsible supply chain


Reducing greenhouse gas emissions, waste, and water use


Giving back to our communities by investing our time, talents, and resources to serve patients and promote science, technology, engineering, and mathematics (STEM) education and training

We produce more than 74 billion doses each year from a network of more than 50 manufacturing sites, and support over 3,000 clinical trial protocols through 50+ clinical depots.

We aim to be the world’s most trusted, reliable and innovative development and manufacturing partner for drugs, biologics, cell and gene therapies, and consumer health products.


Patient First | People | Integrity | Customer Dedication | Innovation | Excellence


We are committed to upholding the highest standards of business conduct in everything we do and we expect our suppliers to do the same.


We have a clear structure to manage our corporate responsibility activities and we listen to stakeholders to help us identify our areas of impact.

Click on the image to download a copy of our FY20 Corporate Responsibility Report.
For more information on Corporate Responsibility & Sustainability at Catalent, email us or follow #CatalentCares on social media.